This review article summarizes the latest progress in research regarding bioapplications of graphene oxide derivatives and provides expert opinions on strategies for overcoming the current challenges.
Exosomes are cell-derived vesicles containing heterogeneous active biomolecules such as
proteins, lipids, mRNAs, receptors, immune regulatory molecules, and nucleic acids. They
typically range in size from 30 to 150 nm in diameter. An exosome’s surfaces can
be bioengineered with antibodies, fluorescent dye, peptides, and tailored for small
molecule and large active biologics. Exosomes have enormous potential as a drug delivery
vehicle due to enhanced biocompatibility, excellent payload capability, and reduced
immunogenicity compared to alternative polymeric-based carriers. Because of active
targeting and specificity, exosomes are capable of delivering their cargo to
exosome-recipient cells. Additionally, exosomes can potentially act as early stage
disease diagnostic tools as the exosome carries various protein biomarkers associated
with a specific disease. In this review, we summarize recent progress on exosome
composition, biological characterization, and isolation techniques. Finally, we outline
the exosome’s clinical applications and preclinical advancement to provide an
outlook on the importance of exosomes for use in targeted drug delivery, biomarker
study, and vaccine development.
The combined delivery of photo- and chemo-therapeutic agents is an emerging strategy to overcome drug resistance in treating cancer, and controlled light-responsive drug release is a proven tactic to produce a continuous therapeutic effect for a prolonged duration. Here, a combination of light-responsive graphene, chemo-agent doxorubicin and pH-sensitive disulfide-bond linked hyaluronic acid form a nanogel (called a graphene-doxorubicin conjugate in a hyaluronic acid nanogel) that exerts an activity with multiple effects: thermo and chemotherapeutic, real-time noninvasive imaging, and light-glutathione-responsive controlled drug release. The nanogel is mono-dispersed with an average diameter of 120 nm as observed by using TEM and a hydrodynamic size analyzer. It has excellent photo-luminescence properties and good stability in buffer and serum solutions. Graphene itself, being photoluminescent, can be considered an optical imaging contrast agent as well as a heat source when excited by laser irradiation. Thus the nanogel shows simultaneous thermo-chemotherapeutic effects on noninvasive optical imaging. We have also found that irradiation enhances the release of doxorubicin in a controlled manner. This release synergizes therapeutic activity of the nanogel in killing tumor cells. Our findings demonstrate that the graphene-doxorubicin conjugate in the hyaluronic acid nanogel is very effective in killing the human lung cancer cell line (A549) with limited toxicity in the non-cancerous cell line (MDCK).
Because of the superiority of GQDs (graphene quantum dots) in biomedical imaging, in terms of biocompatibility and toxicity of semiconductor quantum dots, GQDs bring new opportunities for the diagnosis and detection of diseases. In this study, we synthesized photoluminescent (PL) graphene quantum dots (GQDs) through a simple exfoliation and oxidation process, and then coated them with polydopamine (pDA) for enhanced stability in water and low toxicity in vivo. From the results, the GQDs coated with pDA showed an excellent stability of PL intensity. It showed that the PL intensity of noncoated GQDs in PBS solution rapidly decreased with time, resulting in a 45% reduction of the PL intensity for 14 days of incubation in PBS solution. After coating with polydopamine, PL intensities of polydopamine-coated GQDs was maintained more stably for 14 days compared with uncoated GQDs. We have observed the in vitro and in vivo biocompatibility of pDA-coated GQDs in nude mice. The overall observation revealed that pDA-coated GQDs could be used as a long-term optical imaging agent as well as a biocompatible drug carrier.
Rheumatoid arthritis (RA) is an autoimmune disease that affects 1-2% of the human population worldwide, and effective therapies with targeted delivery for local immune suppression have not been described. We address this problem by developing a novel theranostic nanoparticle for RA and assessed its therapeutic and targeting effects under image-guidance.
Methods:
Albumin-cerium oxide nanoparticles were synthesized by the biomineralization process and further conjugated with near-infrared, indocyanine green (ICG) dye. Enzymatic-like properties and reactive oxygen species (ROS) scavenging activities, as well as the ability to reprogram macrophages, were determined on a monocyte cell line in culture. The therapeutic effect and systemic targeting potential were evaluated in collagen-induced arthritis (CIA) mouse model using optical/optoacoustic tomographic imaging.
Results:
Small nanotheranostics with narrow size distribution and high colloidal stability were fabricated and displayed high ROS scavenging and enzymatic-like activity, as well as advanced efficacy in a converting pro-inflammatory macrophage phenotype into anti-inflammatory phenotype. When administrated into affected animals, these nanoparticles accumulated in inflamed joints and revealed a therapeutic effect similar to the gold-standard therapy for RA, methotrexate.
Conclusions:
The inflammation-targeting, inherent contrast and therapeutic activity of this new albumin-cerium oxide nanoparticle may make it a relevant agent for assessing severity in RA, and other inflammatory diseases, and controlling inflammation with image-guidance. The design of these nanotheranostics will enable potential clinical translation as systemic therapy for RA.
Bioinspired materials have received substantial attention across biomedical, biological, and drug delivery research because of their high biocompatibility and lower toxicity compared with synthetic materials.
Although
white-light-emitting nanomaterials are capable of generating multichannel
fluorescence emissions, their acute toxicity in the biological system
limited their biomedical applications. This article details the fabrication
of water-soluble, biocompatible, single-phosphor white-light-emitting
carbon nano-onions (WCNOs) and presents them as a novel multichannel
fluorescence nanoprobe for bioimaging and biosensing applications.
FE-TEM results confirmed the fabrication of WCNOs. In vitro and in vivo studies confirmed the uptake and multichannel
fluorescence emissions from WCNOs in all three primitive channels
(blue, green, and red). Furthermore, WCNOs showed increased tumor
accumulation, with a safe elimination through the liver and kidneys.
For further investigation of their application as a stimuli-responsive
functional nanoprobe, the surfaces of WCNOs were coated with manganese
oxide (WCNO-MnO2) nanosheets, which not only quenched the
fluorescence of WCNO, but also reacted with the glutathione (GSH)
in the biological environments. Results showed that GSH can etch the
MnO2 on the surface of WCNO-MnO2 and aid in
the GSH-responsive fluorescence recovery from WCNOs. In vitro and in vivo results further demonstrated GSH-responsive
multichannel bioimaging from WCNO-MnO2. These results confirmed
WCNOs as a novel, biocompatible multichannel fluorescence nanoprobe,
that can be used for diverse biomedical applications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.